Archive: 15/10/2019
Global trial is first clear evidence that widely available drug reduces head injury deaths
A low cost and widely available drug could reduce deaths in traumatic brain injury patients by as much as 20%, depending on the severity of injury, according to a major study published in The Lancet. The researchers say that ...
Oct 15, 2019